India’s vaccine against COVID-19 Covaxin is set to get closer to World Health Organization (WHO) approval. Amid the wait for the WHO approval to India-made COVID-19 vaccine Covaxin, the chief scientist of the UN Organisation, Soumya Swaminathan, on Friday said that the phase 3 clinical data of Bharat Biotech's Covaxin looks promising and the vaccine may get the WHO's approval by mid-August.
"I think the Phase-3 trial data of Covaxin is good and encouraging. The good thing is that they have also looked at the variants and they are sequenced about 60 per cent of the breakthrough variants that were seen in the trial. The overall efficacy is high while efficacy against the Delta variant is comparatively low, but it's still very good," Soumya Swaminathan said.
Bharat Biotech, which in association with Indian Council for Medical Research (ICMR) has developed the whole-virion inactivated vaccine, last month said the WHO approval was expected in the July-September quarter. The WHO had then said the application was submitted in April 19 and more information was needed. A pre-submission meeting was scheduled in May-June, the U.N. agency had said.
U’khand CM says decision on Kanwar Yatra after consultation with neighbouring states
Good News: This medicine will end corona infection from the body in 5 days!
Pinarayi Vijayan calls for PM Modi to waive duty on life-saving drug for kids